相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Very-Low-Density Lipoprotein- Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
Raimund Pechlaner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol
Salam Ibrahim et al.
CARDIOVASCULAR RESEARCH (2016)
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Kiran Musunuru et al.
CIRCULATION RESEARCH (2016)
Targeting ApoC-III to Reduce Coronary Disease Risk
Sumeet A. Khetarpal et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
Xiaohong Yang et al.
JOURNAL OF LIPID RESEARCH (2016)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Frederick F. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
Arman Qamar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
Moritz C. Wyler von Ballmoos et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Developing Medicines That Mimic the Natural Successes of the Human Genome Lessons From NPC1L1, HMGCR, PCSK9, APOC3, and CETP*
Sekar Kathiresan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do et al.
NATURE (2015)
Association of Low-Frequency and Rare Coding-Sequence Variants with Blood Lipids and Coronary Heart Disease in 56,000 Whites and Blacks
Gina M. Peloso et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
AAV Vectors Expressing LDLR Gain-of-Function Variants Demonstrate Increased Efficacy in Mouse Models of Familial Hypercholesterolemia
Suryanarayan Somanathan et al.
CIRCULATION RESEARCH (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia
Sadik H. Kassim et al.
HUMAN GENE THERAPY (2013)
Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
Mikael Larsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia
Shu-Jen Chen et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
Sandrine Caron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Apolipoprotein CIII 42 Years Old and Even More Interesting
Henry N. Ginsberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
Esther M. M. Ooi et al.
JOURNAL OF LIPID RESEARCH (2011)
Investigations of apoC-III metabolism using stable isotopes: what information can you acquire and how can you interpret your results?
Henry N. Ginsberg et al.
JOURNAL OF LIPID RESEARCH (2011)
Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men
Min-Jeong Shin et al.
ATHEROSCLEROSIS (2010)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
Meenakshi Sundaram et al.
JOURNAL OF LIPID RESEARCH (2010)
Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results
Henry N. Ginsberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
Tsuguhito Ota et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport
Hiroyuki Tanigawa et al.
CIRCULATION (2007)
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
Minh N. Nguyen et al.
JOURNAL OF LIPID RESEARCH (2006)
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics
DC Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism
Jean-Francois Mauger et al.
JOURNAL OF LIPID RESEARCH (2006)
Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]
WJ Cain et al.
JOURNAL OF LIPID RESEARCH (2005)
Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339
JS Millar et al.
JOURNAL OF LIPID RESEARCH (2005)
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
K Nagashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
JS Cohn et al.
JOURNAL OF LIPID RESEARCH (2003)
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
O Olivieri et al.
JOURNAL OF LIPID RESEARCH (2003)
Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
DC Chan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
分享论文
